deferoxamine has been researched along with Absence Seizure in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holmes, DT; Sreenivasan, GM; Yong, RL | 1 |
| Bentivoglio, AR; Colosimo, C; Fasano, A; Miyajima, H; Re, TJ; Tonali, PA | 1 |
| Rubin, JJ; Willmore, LJ | 1 |
| Erasmus, RT; Herman, MM; Kusnir, J; Lobo, P; Savory, J; Stevenson, WC; Wills, MR | 1 |
| McCauley, J; Sorkin, MI | 1 |
| Corwin, HL; Mayor, GH; Sprague, SM; Tanner, CM; Wilson, RS | 1 |
6 other study(ies) available for deferoxamine and Absence Seizure
| Article | Year |
|---|---|
Aluminum toxicity due to intravenous injection of boiled methadone.
Topics: Adult; Aluminum; Ataxia; Chelation Therapy; Deferoxamine; Dysarthria; Humans; Male; Methadone; Poisoning; Seizures; Substance Abuse, Intravenous | 2006 |
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.
Topics: Brain; Ceruloplasmin; Deferoxamine; Diabetes Mellitus; Disease Progression; Family; Female; Heredodegenerative Disorders, Nervous System; Humans; Iron; Iron Chelating Agents; Iron Overload; Magnetic Resonance Imaging; Male; Metal Metabolism, Inborn Errors; Middle Aged; Mutation; Phenotype; Seizures | 2008 |
Prevention of iron-induced epileptiform discharges in rats by treatment with antiperoxidants.
Topics: Animals; Cerebral Cortex; Deferoxamine; Electroencephalography; Evoked Potentials; Ferrous Compounds; Rats; Seizures; Selenium; Vitamin E | 1980 |
Hyperaluminemia associated with liver transplantation and acute renal failure.
Topics: Acute Kidney Injury; Albumins; Aluminum; Ammonia; Antidotes; Chelating Agents; Coma; Deferoxamine; Dialysis Solutions; Enteral Nutrition; Female; Food Additives; Food, Formulated; Humans; Liver; Liver Transplantation; Middle Aged; Organic Chemicals; Renal Dialysis; Seizures | 1995 |
Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
Topics: Aged; Aluminum Hydroxide; Deferoxamine; Hallucinations; Humans; Male; Memory Disorders; Middle Aged; Renal Dialysis; Seizures; Speech Disorders | 1989 |
Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
Topics: Aluminum; Deferoxamine; Dementia; Female; Humans; Kidney Failure, Chronic; Middle Aged; Myoclonus; Renal Dialysis; Seizures | 1986 |